WallStreetZenWallStreetZen

NASDAQ: BIIB
Biogen Inc Earnings & Revenue

BIIB past earnings growth

How has BIIB's earnings growth performed historically?
Company
-62.8%
Industry
19%
Market
130.54%
BIIB's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
BIIB's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
BIIB's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

BIIB past revenue growth

How has BIIB's revenue growth performed historically?
Company
-4.37%
Industry
9.63%
Market
19.55%
BIIB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BIIB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BIIB's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BIIB earnings and revenue history

Current Revenue
$9.7B
Current Earnings
$1.2B
Current Profit Margin
12.1%
BIIB's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

BIIB Return on Equity

Current Company
7.9%
Current Industry
34.9%
Current Market
28.2%
BIIB's Return on Equity (7.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BIIB announces earnings.

BIIB Return on Assets

Current Company
4.4%
Current Industry
8.2%
BIIB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BIIB Return on Capital Employed

Current Company
5.67%
Current Industry
14.4%
BIIB's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BIIB vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BIIB$9.66B$1.85B$1.17B-6.89%-19.14%
OGN$6.35B$1.44B$1.05B+24.23%-76.10%
GRFS$7.09B$1.23B$63.78M+7.27%-36.90%
AMRN$277.46M-$46.02M-$52.61M+1.42%N/A
SCLX$47.05M-$101.67M-$107.96M+11.08%N/A

BIIB earnings dates

Next earnings date
Jun 20, 2024

Biogen Earnings & Revenue FAQ

What were BIIB's earnings last quarter?

On Invalid Date, Biogen (NASDAQ: BIIB) reported Q1 2024 earnings per share (EPS) of $2.71, up 0.74% year over year. Total Biogen earnings for the quarter were $393.40 million. In the same quarter last year, Biogen's earnings per share (EPS) was $2.69.

If you're new to stock investing, here's how to buy Biogen stock.

What was BIIB's earnings growth in the past year?

As of Q2 2024, Biogen's earnings has grown -62.8% year over year. This is 81.8 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 19%. Biogen's earnings in the past year totalled $1.17 billion.

What is BIIB's earnings date?

Biogen's earnings date is Invalid Date. Add BIIB to your watchlist to be reminded of BIIB's next earnings announcement.

What was BIIB's revenue last quarter?

On Invalid Date, Biogen (NASDAQ: BIIB) reported Q1 2024 revenue of $2.29 billion up 7% year over year. In the same quarter last year, Biogen's revenue was $2.46 billion.

What was BIIB's revenue growth in the past year?

As of Q2 2024, Biogen's revenue has grown -4.37% year over year. This is 14 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 9.63%. Biogen's revenue in the past year totalled $9.66 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.